CancerCare Manitoba
Tools You can Use

♦   ♦   ♦

Canadian Task Force on Preventive Health Care Guidelines

This handy card is a collaborative effort between UPCON, the CancerCare Manitoba Foundation, and the Manitoba Breast Screening Program.

Estimate Benefit of Post-Surgical Cancer Treatment

  • Adjuvant! Online is a web resource that helps doctors estimate the benefits and risks of having additional (adjuvant) chemotherapy or hormone therapy after surgery for early stage breast and colorectal cancer. This includes estimated reductions in relapse rates and mortality with these treatments. Information needed includes age, tumour size and grade, and nodal involvement. This program is free but requires registration. Familiarity with cancer and cancer therapy is required to apply this tool accurately. Helpful graphics for use in discussion with patients are included, and it available for Palm OS and Pocket PCs. Your Internet browser must support Java.

Estimate Risk of Breast Cancer

  • The NCI Breast Cancer Risk Assessment Tool is a simple web-based tool that uses the Gail Model to assess your patient's risk of getting breast cancer in the future. Information about age at menarche, parity and family history is needed. Calculations like this are used to assess the need for "chemoprevention" with tamoxifen or other treatments for women at increased risk.
Telephone Support
• Assistance and advice for physicians regarding opioid use for cancer patients is available through-
CCMB Symptom Management physicians:
Dr. Paul Daeninck
(204) 237-2053
Dr. Jeff Sisler
(204) 931-2824
The WHRA Palliative Care Program:
Doctor On Call:
(204) 237-2053

Opioid Conversion

  • The Hopkins Opioid Conversion Program from Johns Hopkins University provides a helpful calculator for switching from one opioid to another or between routes of administration. Registration is required but the site is free.
  • A helpful Canadian link is to the University of Alberta Pain Centre website, but the calculations on this site are manual.

    Both sites emphasize the importance of caution and experience in interpreting the results and of reducing calculated doses by about 30% because of the incomplete cross-tolerance that is often evident when opioid switches are made.

Treatment Decision Tools

  • The American Cancer Society website has Treatment Decision Tools that are helpful to patients and physicians in understanding the pros and cons of cancer treatments available for different kinds of cancers.